ArticleInternational journal of biological sciences2023

Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation.

Yi-Ru Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.